T1D Fund Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 15
Professionals
  • Investments
  • 30
  • Portfolio
  • 20
  • Exits
  • 6
Exits

T1D Fund General Information

Description

Founded in 2016, T1D Fund is a venture capital firm based in Boston, Massachusetts. The firm seeks to invest in the healthcare sector and invests in products and therapies that enable people with T1D, or those at risk of developing it, to lead a more normal and longer life.

Contact Information

Website
www.t1dfund.org
Year Founded
2016
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • Boston, MA
  • United States

T1D Fund Investments (30)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Code Bio 20-Apr-2021 Seed Round 0000 Biotechnology Generating Revenue
0000000 09-Feb-2021 00000 00000 0000 Therapeutic Devices Generating Revenue
0000000 28-Jan-2021 00000 00000 000.00 Drug Discovery Generating Revenue
000 000000000000 01-Dec-2020 0000 00000 00.00 Drug Delivery Startup 00000 000000
00000000 000000000 30-Nov-2020 0000 00000 00.00 Drug Delivery Generating Revenue 00000 000000
000000 00000000000 30-Sep-2020 00000 00000 0000 Drug Discovery Startup
000000000 08-Sep-2020 00000 00000 0000 Drug Discovery Clinical Trials - General
00000 000000000000 17-Aug-2020 00000 00000 000.00 Drug Delivery Generating Revenue
Diogenx 16-Jun-2020 Seed Round 000 Drug Discovery Pre-Clinical Trials 00000 000000
SQZ Biotech 18-May-2020 Later Stage VC 0000 Drug Delivery Generating Revenue/Not Profitable 000000 000000 00.0
You’re viewing 10 of 30 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

T1D Fund Exits (6)

Company Name Exit Date Exit Type Exit Size
Immunocore 05-Feb-2021 IPO 00000
00000000 08-Jan-2021 000 00 00000000
000 0000000 30-Oct-2020 000 000.00
0000000 0000000000 17-Jul-2020 000 00000
Semma Therapeutics 10-Oct-2019 Merger/Acquisition 00000
Provention Bio 24-Jul-2018 IPO 000.00
To view T1D Fund’s complete exits history, request access »

T1D Fund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

T1D Fund Team (19)

Name Title Deals Funds Boards Office
Steven Peter MD Managing Director & Chairman 0 Boston, MA
Katie Ellias Managing Director 0 0 0 Boston, MA
Bruce Buckingham MD Partner & Advisor Boston, MA
Carmella Evans-Molina Ph.D Partner & Advisor Boston, MA
Chantal Mathieu Ph.D Partner & Advisor Boston, MA
You’re viewing 5 of 19 team members. Get the full list »

T1D Fund Co-Investors (122)

Name With Exits Lead Partner Series Industry
ARCH Venture Partners 3 0 0 Series chart Industry bar
Polaris Partners 0 0 0 Series chart Industry bar
Alexandria Venture Investments 0 Series chart Industry bar
Eli Lilly and Company Foundation 0 Series chart Industry bar
Roche Venture Fund 0 0 Series chart Industry bar
You’re viewing 5 of 122 co-investors. Get the full list »